Acadia Pharmaceuticals: Needham cuts target price to $35 from $41
ACAD•Needham cut its target price for Acadia Pharmaceuticals to $35 from $41.
Related News
IDEAYA Biosciences grants 94,000 inducement stock options at $36.74 a share
IDYA•
UK shares set for weekly gains as oil prices retreat
EWU•
Acadia Pharmaceuticals target price cut to $34 from $36
ACAD•
TSX futures edge up as oil eases, precious metals gain
EWC•
Everpure Inc: Susquehanna raises target price to $175 from $145
P•